Open AccessAdverse outcome of mucormycosis in patients with non-Hodgkin’s lymphoma (clinical observation)
Author(s) -
Е. А. Михайлова,
С. А. Кулева,
С. В. Иванова,
Э. Д. Гумбатова,
А. С. Артемьева,
А. В. Хохлова,
Ilya Burovik,
А. Б. Косичкина
Publication year - 2019
Publication title -
rossijskij žurnal detskoj gematologii i onkologii
Language(s) - English
Resource type - Journals
eISSN - 2413-5496
pISSN - 2311-1267
DOI - 10.21682/2311-1267-2019-6-3-72-76
Subject(s) - mucormycosis , immunosuppression , lymphoma , medicine , aspergillosis , adverse effect , hodgkin lymphoma , intensive care medicine , pathology , immunology
Over the past two decades, mucormycosis has firmly taken 3 rd place among invasive mycoses after candidiasis and aspergillosis in patients with oncohematological diseases. The article presents a clinical case of disseminated mucormycosis that developed in a child with nonHodgkin’s lymphoma on the background of deep immunosuppression.